Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment

AC Garrido-Castro, NU Lin, K Polyak - Cancer discovery, 2019 - AACR
Triple-negative breast cancer (TNBC) remains the most challenging breast cancer subtype
to treat. To date, therapies directed to specific molecular targets have rarely achieved …

Emerging roles of C-Myc in cancer stem cell-related signaling and resistance to cancer chemotherapy: a potential therapeutic target against colorectal cancer

M Elbadawy, T Usui, H Yamawaki, K Sasaki - International journal of …, 2019 - mdpi.com
Myc is a nuclear transcription factor that mainly regulates cell growth, cell cycle, metabolism,
and survival. Myc family proteins contain c-Myc, n-Myc, and l-Myc. Among them, c-Myc can …

Hypoxic Glioma Stem Cell–Derived Exosomes containing Linc01060 promote progression of Glioma by regulating the MZF1/c-Myc/HIF1α axis

J Li, T Liao, H Liu, H Yuan, T Ouyang, J Wang, S Chai… - Cancer research, 2021 - AACR
Glioma stem cells (GSC) are a subpopulation of tumor cells with special abilities to
proliferate and differentiate in gliomas. They are one of the main causes of tumor recurrence …

The role for Myc in coordinating glycolysis, oxidative phosphorylation, glutaminolysis, and fatty acid metabolism in normal and neoplastic tissues

ES Goetzman, EV Prochownik - Frontiers in endocrinology, 2018 - frontiersin.org
That cancer cells show patterns of metabolism different from normal cells has been known
for over 50 years. Yet, it is only in the past decade or so that an appreciation of the benefits …

Synthetic lethality of PARP inhibitors in combination with MYC blockade is independent of BRCA status in triple-negative breast cancer

JPW Carey, C Karakas, T Bui, X Chen… - Cancer research, 2018 - AACR
PARP inhibitors (PARPi) benefit only a fraction of breast cancer patients. Several of those
patients exhibit intrinsic/acquired resistance mechanisms that limit efficacy of PARPi …

Biological rationale for targeting MEK/ERK pathways in anti-cancer therapy and to potentiate tumour responses to radiation

F Marampon, C Ciccarelli, BM Zani - International journal of molecular …, 2019 - mdpi.com
ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are evolutionary-
conserved and ubiquitous serine-threonine kinases involved in regulating cell signalling in …

Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines

S Codenotti, M Poli, M Asperti, D Zizioli… - Journal of cancer …, 2018 - Springer
Purpose Ferroptosis is a programmed form of iron-dependent cell death caused by lipid
hydroperoxide accumulation, which can be prevented by glutathione peroxidase 4 (GPx4) …

MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma

N Abdelfattah, S Rajamanickam, S Panneerdoss… - Nature …, 2018 - nature.com
Despite improvements in overall survival, only a modest percentage of patients survives
high-risk medulloblastoma. The devastating side effects of radiation and chemotherapy …

DNA repair and cytokines: TGF-β, IL-6, and thrombopoietin as different biomarkers of radioresistance

L Centurione, FB Aiello - Frontiers in oncology, 2016 - frontiersin.org
Double strand breaks (DSBs) induced by radiotherapy are highly cytotoxic lesions, leading
to chromosomal aberrations and cell death. Ataxia-telangiectasia-mutated (ATM)-dependent …

Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo

C Ciccarelli, A Di Rocco, GL Gravina, A Mauro… - Journal of Cancer …, 2018 - Springer
Abstract Purpose Prostate cancer (PCa) cell radioresistance causes the failure of radiation
therapy (RT) in localized or locally advanced disease. The aberrant accumulation of c-Myc …